These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22820187)

  • 1. Epigenetic genes regulated by the BRAFV600E signaling are associated with alterations in the methylation and expression of tumor suppressor genes and patient survival in melanoma.
    Liu D; Liu X; Xing M
    Biochem Biophys Res Commun; 2012 Aug; 425(1):45-50. PubMed ID: 22820187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BRAF(V600E) causes widespread alterations in gene methylation in the genome of melanoma cells.
    Hou P; Liu D; Dong J; Xing M
    Cell Cycle; 2012 Jan; 11(2):286-95. PubMed ID: 22189819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
    Guo X; Xu Y; Zhao Z
    Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.
    Marini A; Mirmohammadsadegh A; Nambiar S; Gustrau A; Ruzicka T; Hengge UR
    J Invest Dermatol; 2006 Feb; 126(2):422-31. PubMed ID: 16374457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
    de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
    Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
    Cao YM; Gu J; Zhang YS; Wei WJ; Qu N; Wen D; Liao T; Shi RL; Zhang L; Ji QH; Wang Y; Sun GH; Zhao YX; Wang YJ; Yu J; Zhu YX
    Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis.
    Yamamoto Y; Matsusaka K; Fukuyo M; Rahmutulla B; Matsue H; Kaneda A
    Cancer Med; 2020 Oct; 9(19):7194-7204. PubMed ID: 32406600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Myc is Required for BRAF
    Qu Y; Yang Q; Liu J; Shi B; Ji M; Li G; Hou P
    Theranostics; 2017; 7(7):2092-2107. PubMed ID: 28656062
    [No Abstract]   [Full Text] [Related]  

  • 9. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
    Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
    Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
    Loria R; Bon G; Perotti V; Gallo E; Bersani I; Baldassari P; Porru M; Leonetti C; Di Carlo S; Visca P; Brizzi MF; Anichini A; Mortarini R; Falcioni R
    Oncotarget; 2015 Feb; 6(5):2779-93. PubMed ID: 25576923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic BRAFV600E induces expression of neuronal differentiation marker MAP2 in melanoma cells by promoter demethylation and down-regulation of transcription repressor HES1.
    Maddodi N; Bhat KM; Devi S; Zhang SC; Setaluri V
    J Biol Chem; 2010 Jan; 285(1):242-54. PubMed ID: 19880519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.
    Hoon DS; Spugnardi M; Kuo C; Huang SK; Morton DL; Taback B
    Oncogene; 2004 May; 23(22):4014-22. PubMed ID: 15064737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells.
    Mezzanotte JJ; Hill V; Schmidt ML; Shinawi T; Tommasi S; Krex D; Schackert G; Pfeifer GP; Latif F; Clark GJ
    Epigenetics; 2014 Nov; 9(11):1496-503. PubMed ID: 25482183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAFV600E Expression Is Homogenous and Associated with Nonrecurrent Disease and Better Survival in Primary Melanoma.
    Naimy S; Bzorek M; Eriksen JO; Dyring-Andersen B; Rahbek Gjerdrum LM
    Dermatology; 2023; 239(3):409-421. PubMed ID: 36657398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.
    Goedert L; Pereira CG; Roszik J; Plaça JR; Cardoso C; Chen G; Deng W; Yennu-Nanda VG; Silva WA; Davies MA; Espreafico EM
    Oncotarget; 2016 Jun; 7(24):36711-36718. PubMed ID: 27167340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAFV600E negatively regulates the AKT pathway in melanoma cell lines.
    Chen B; Tardell C; Higgins B; Packman K; Boylan JF; Niu H
    PLoS One; 2012; 7(8):e42598. PubMed ID: 22880048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
    Jonsson A; Tuominen R; Grafström E; Hansson J; Egyhazi S
    J Invest Dermatol; 2010 Dec; 130(12):2809-17. PubMed ID: 20703244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation characteristics of primary melanomas with distinct biological behaviour.
    Ecsedi S; Hernandez-Vargas H; Lima SC; Vizkeleti L; Toth R; Lazar V; Koroknai V; Kiss T; Emri G; Herceg Z; Adany R; Balazs M
    PLoS One; 2014; 9(5):e96612. PubMed ID: 24832207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.